PMID: 9187813Jun 1, 1997Paper

Pulmonary rehabilitation and surgery for end-stage lung disease

Clinics in Chest Medicine
S Kesten

Abstract

Pulmonary rehabilitation is a multidisciplinary approach to the comprehensive management of patients with end-stage lung disease. Components of the pulmonary rehabilitation program include education, exercise, nutrition, and psychosocial support. Most of the information published on pulmonary rehabilitation has been from patients with COPD. There are some data on patients with cystic fibrosis but, unfortunately, there is a lack of information on other causes of end-stage lung disease. Published data almost invariably show improvements in functional capacity (i.e., walk distance) and quality of life. There are no objective physiologic changes in lung function. Because patients who attend programs regularly are a carefully selected subpopulation, conclusions from published reports may not apply to all patients with end-stage lung disease. The recommendation for pulmonary rehabilitation prior to lung volume reduction surgery or lung transplantation is based on assumptions that may not necessarily be true. No data exist that conclusively show that preoperative rehabilitation alters outcome. Nevertheless, given the relatively benign nature of pulmonary rehabilitation and the documented benefits, it is reasonable to recommend such a ...Continue Reading

References

Sep 1, 1979·The Journal of Pediatrics·H P ChaseM H Lavin
Aug 12, 1976·The New England Journal of Medicine·R C DoekelJ V Weil
Apr 1, 1977·Clinical Science and Molecular Medicine·I GertzJ Wahren
Apr 13, 1991·Lancet·A WakabayashiA F Wilson
Jan 1, 1987·British Journal of Diseases of the Chest·G H GuyattS O Pugsley
Jun 1, 1970·Journal of Applied Physiology·R E MuellerG F Filley
Jun 1, 1984·Chest·R M RogersM Irwin
Aug 1, 1984·Journal of Consulting and Clinical Psychology·C J AtkinsK Lofback
Oct 1, 1995·The Annals of Thoracic Surgery·A Wakabayashi
Sep 1, 1995·American Journal of Respiratory and Critical Care Medicine·B R Celli
May 1, 1995·American Journal of Respiratory and Critical Care Medicine·C T BolligerM Tamm
Jan 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·J D CooperC L Roper
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·A P Fishman
Aug 7, 1993·British Dental Journal·C Emery
Feb 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·H A GaissertG A Patterson
Feb 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·R J KeenanC M Bowers
May 1, 1996·The Annals of Thoracic Surgery·J I MillerK A Mansour

❮ Previous
Next ❯

Citations

Sep 27, 2001·Anesthesiology Clinics of North America·P D Slinger, M R Johnston
May 4, 2000·Journal of Cardiothoracic and Vascular Anesthesia·P D Slinger, M R Johnston
Apr 22, 1999·Thorax·N M SiafakasD Georgopoulos
Aug 26, 1998·Seminars in Thoracic and Cardiovascular Surgery·T K Waddell, S Keshavjee
Mar 3, 2009·Transplantation Proceedings·P E MunroG I Snell
Apr 20, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Alfredo CesarioPierluigi Granone
Feb 28, 2006·Archives of Physical Medicine and Rehabilitation·Augusta S AlbaMatthew N Bartels
Feb 15, 2005·Thoracic Surgery Clinics·Peter D Slinger, Michael R Johnston
Jan 5, 2002·AACN Clinical Issues·D M Lanuza, M A McCabe
Apr 3, 2012·International Journal of Rheumatic Diseases·Monique ChaayaImad Uthman
Oct 4, 2006·Current Opinion in Anaesthesiology·J Behr
Apr 25, 2000·Current Problems in Surgery·J B ShragerJ D Edelman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.